These experiments identified both pathways previously associated with ALS (e.g., translation, mitochondrial function [8, 96]) and novel targets of TDP-43 mediated translational inhibition including the Wg/Wnt signaling regulator dlp and the glutathione metabolism pathway. Here, TXNL4B is linked to amyotrophic lateral sclerosis.